Blog & Resources

How New Experiences Support Brain Health

Looking after our brains is just as important as looking after our bodies. At Re:Cognition Health, we often emphasise that keeping the mind active is key to […]

A Breakthrough in Treating Degenerative Brain Diseases

In her compelling TEDx Athens Salon talk, delivered as part of the TEDx Global Idea Search, Dr Emer MacSweeney, CEO and Consultant Neuroradiologist at Re:Cognition Health, presented […]

Alzheimer’s Fingerprick Tests: Why Blood-Based Biomarker Trials Matter

Early diagnosis has long been one of the greatest challenges in Alzheimer’s disease. For decades, clinicians have been forced to rely on expensive brain scans, invasive lumbar […]

Say hello to the Re:Cognition Health Brain and Mind Foundation!

Nearly half of the world’s population is affected by a neurological condition. It is a staggering statistic –  and one that becomes even more alarming when we […]

How a Single Brain Scan Could Predict Biological Aging

Aging is an inevitable part of life, but why do some people appear to age more slowly than others? Whilst  genetics account for roughly a quarter of […]

Americans Call for Early Alzheimer’s Detection and Risk-Taking Treatments Amidst Soaring Prevalence

In a year where the number of Americans living with Alzheimer’s disease has surpassed 7 million for the first time, a new report from the Alzheimer’s Association […]

Re:Cognition Health Becomes the First Organization to Earn Internationally Recognized GCSA Certification in the US and Europe

At Re:Cognition Health, we are proud to announce a monumental achievement: we have become the first organization to earn the prestigious GCSA Certification in both the US […]

The Benefits of Alzheimer’s Clinical Trials

This is an exciting time for Alzheimer’s clinical trials, with leaps and bounds of progress in the development of new-generation treatments over the last few years. Due […]

Dr. Emer MacSweeney talks new treatments on Good Morning Washington

New Alzheimer’s Disease Prevention Developments

A recent study from R. Scott Turner, PHD, MD–one of our Principal Investigators at Re:Cognition Health USA–shows that both mild cognitive impairment (MCI) and dementia cases are […]